Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 7/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.38 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | TBXAS1 | P24557 | 5/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11980103 | 0.84 | CYP19A1 (0.34) | ELANECYP19A1CYP11B1CYP11B2ABL1 | |
| SCHEMBL31388182 | 0.81 | CYP19A1 (0.52) | CYP19A1CYP11B1CYP11B2ABL1HTT | |
| SCHEMBL11110140 | 0.79 | CYP19A1 (0.55) | CYP19A1TBXAS1KMT2A | |
| SCHEMBL13028396 | 0.78 | FAAH (0.46) | CYP19A1TBXAS1HTTMEN1CYP3A4 | |
| SCHEMBL9807751 | 0.78 | CYP19A1 (0.46) | CYP19A1TBXAS1HTTCYP3A4 | |
| SCHEMBL22242602 | 0.77 | ELANE (0.50) | ELANECYP19A1TBXAS1HTTMEN1 | |
| SCHEMBL13028410 | 0.76 | CYP3A4 (0.41) | ELANECYP19A1HTTMEN1CYP3A4 | |
| SCHEMBL9878041 | 0.76 | MEN1 (0.47) | CYP19A1MEN1KMT2A | |
| SCHEMBL11106769 | 0.74 | MAOB (0.46) | ELANECYP19A1CYP11B1CYP11B2CYP3A4 | |
| SCHEMBL30580646 | 0.74 | LTA4H (0.47) | ELANECYP19A1CYP11B1CYP11B2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8236842-B2 | Salt and process for producing acid generator | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-07 | — | — | US | disclosed |
| US-20110201823-A1 | SALT AND PROCESS FOR PRODUCING ACID GENERATOR | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110201823-A1 | SALT AND PROCESS FOR PRODUCING ACID GENERATOR | FGFR1, MTX1, RER1 | ELANE 2800/4885CYP19A1 924/4885CYP11B1 106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.